» Articles » PMID: 21412425

Purified Mesenchymal Stem Cells Are an Efficient Source for IPS Cell Induction

Overview
Journal PLoS One
Date 2011 Mar 18
PMID 21412425
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Induced pluripotent stem (iPS) cells are generated from mouse and human somatic cells by the forced expression of defined transcription factors. Although most somatic cells are capable of acquiring pluripotency with minimal gene transduction, the poor efficiency of cell reprogramming and the uneven quality of iPS cells are still important problems. In particular, the choice of cell type most suitable for inducing high-quality iPS cells remains unclear.

Methodology/principal Findings: Here, we generated iPS cells from PDGFRα+ Sca-1+ (PαS) adult mouse mesenchymal stem cells (MSCs) and PDGFRα⁻ Sca-1⁻ osteo-progenitors (OP cells), and compared the induction efficiency and quality of individual iPS clones. MSCs had a higher reprogramming efficiency compared with OP cells and Tail Tip Fibroblasts (TTFs). The iPS cells induced from MSCs by Oct3/4, Sox2, and Klf4 appeared to be the closest equivalent to ES cells by DNA microarray gene profile and germline-transmission efficiency.

Conclusions/significance: Our findings suggest that a purified source of undifferentiated cells from adult tissue can produce high-quality iPS cells. In this context, prospectively enriched MSCs are a promising candidate for the efficient generation of high-quality iPS cells.

Citing Articles

Stem cell therapy for hepatocellular carcinoma and end-stage liver disease.

Abdellateif M, Zekri A J Egypt Natl Canc Inst. 2023; 35(1):35.

PMID: 37926787 DOI: 10.1186/s43046-023-00194-z.


Xeno-free generation of human induced pluripotent stem cells from donor-matched fibroblasts isolated from dermal and oral tissues.

Ali H, Suliman S, Osman T, Carrasco M, Bruland O, Costea D Stem Cell Res Ther. 2023; 14(1):199.

PMID: 37559144 PMC: 10410907. DOI: 10.1186/s13287-023-03403-7.


Mesenchymal stromal cells in the bone marrow niche consist of multi-populations with distinct transcriptional and epigenetic properties.

Kanazawa S, Okada H, Hojo H, Ohba S, Iwata J, Komura M Sci Rep. 2021; 11(1):15811.

PMID: 34349154 PMC: 8338933. DOI: 10.1038/s41598-021-94186-5.


Generation of Induced Pluripotent Stem Cells from Patients with Multiple Myeloma.

Yilmaz Basaran I, Karaoz E Turk J Haematol. 2021; 38(4):254-263.

PMID: 33757979 PMC: 8656131. DOI: 10.4274/tjh.galenos.2021.2020.0682.


Microfluidics as efficient technology for the isolation and characterization of stem cells.

Aghlmandi A, Nikshad A, Safaralizadeh R, Warkiani M, Aghebati-Maleki L, Yousefi M EXCLI J. 2021; 20:426-443.

PMID: 33746671 PMC: 7975637. DOI: 10.17179/excli2020-3028.


References
1.
Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

2.
Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E . Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med. 2009; 206(11):2483-96. PMC: 2768869. DOI: 10.1084/jem.20091046. View

3.
Kim J, Sebastiano V, Wu G, Arauzo-Bravo M, Sasse P, Gentile L . Oct4-induced pluripotency in adult neural stem cells. Cell. 2009; 136(3):411-9. DOI: 10.1016/j.cell.2009.01.023. View

4.
Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

5.
Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P, Natesan S . Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature. 2010; 465(7295):175-81. PMC: 3987905. DOI: 10.1038/nature09017. View